Letter to the Editor
- Page Path
-
- HOME
- ARTICLE CATEGORY
- Letter to the Editor
- Letter to the Editor
- Correspondence on Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
- Jun-Hyuk Lee, Kyongmin Park, Hye Sun Lee, Hoon-Ki Park, Jee Hye Han, Sang Bong Ahn
- Clin Mol Hepatol. 2023;29(1):179-181. Published online November 22, 2022
-
View: 402 Download: 24
- Correspondence on Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
- Ka Shing Cheung, Chiu Hang Mok, Wai Kay Seto, Man Fung Yuen
- Clin Mol Hepatol. 2023;29(1):176-178. Published online November 10, 2022
-
View: 494 Download: 33
- Correspondence on Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”
- Tae Hyung Kim, Young Kul Jung, Hyung Joon Yim
- Clin Mol Hepatol. 2023;29(1):173-175. Published online November 15, 2022
-
View: 418 Download: 21
- Correspondence on Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
- Seung Min Lee, Dae Won Jun
- Clin Mol Hepatol. 2023;29(1):171-172. Published online November 10, 2022
-
View: 442 Download: 27
- Letter regarding “The usefulness of metabolic score for insulin resistance for the prediction of incident non-alcoholic fatty liver disease in Korean adults”
- Hye Won Lee
- Clin Mol Hepatol. 2023;29(1):169-170. Published online November 10, 2022
-
View: 546 Download: 24 Citation: 1
- Letter regarding “COVID-19 vaccine immunogenicity among chronic liver disease patients and liver transplant recipients: A meta-analysis”
- Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
- Clin Mol Hepatol. 2023;29(1):168. Published online October 31, 2022
-
View: 731 Download: 39 Citation: 1
- Letter regarding “Impacts of muscle mass dynamics on prognosis of outpatients with cirrhosis”
- Do Seon Song, U Im Chang, Jin Mo Yang
- Clin Mol Hepatol. 2023;29(1):165-167. Published online October 31, 2022
-
View: 661 Download: 37 Citation: 1
- Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
- Yuanbin Liu, Mingkai Chen
- Clin Mol Hepatol. 2023;29(1):163-164. Published online October 27, 2022
-
View: 611 Download: 36
- Non-alcoholic fatty liver disease and risk of dementia: Unmet need for a pooled analysis of cohort studies
- Seogsong Jeong, Won Kim, Sang Min Park
- Clin Mol Hepatol. 2022;28(4):933-934. Published online September 14, 2022
-
View: 1018 Download: 43
- Non-alcoholic fatty liver disease and the risk of dementia: A meta-analysis of cohort studies
- Li-Yu Lu, Min-You Wu, Yung-Shuo Kao, Cheng-Hsien Hung
- Clin Mol Hepatol. 2022;28(4):931-932. Published online September 5, 2022
-
View: 1066 Download: 68 Citation: 1
- Forms of cholangitis to be considered after SARS-CoV-2 infection
- Ju-Yeon Cho, Young-Sun Lee, Soon Sun Kim, Do Seon Song, Jeong-Hoon Lee, Ji Hoon Kim
- Clin Mol Hepatol. 2022;28(4):929-930. Published online September 8, 2022
-
View: 853 Download: 39
- Autoimmune liver disease represented as primary biliary cholangitis after SARS-CoV-2 infection: A need for population-based cohort study
- Soon Kyu Lee, Jung Hyun Kwon, Nara Yoon, Soon Woo Nam, Pil Soo Sung
- Clin Mol Hepatol. 2022;28(4):926-928. Published online September 5, 2022
-
View: 937 Download: 43 Citation: 1
- Clinical significance of the discrepancy between radiological findings and biochemical responses in atezolizumab plus bevacizumab for hepatocellular carcinoma
- Hideki Iwamoto, Shigeo Shimose, Takashi Niizeki, Hironori Koga, Takuji Torimura
- Clin Mol Hepatol. 2022;28(3):575-579. Published online April 21, 2022
-
View: 1589 Download: 169 Citation: 1
- Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs
- Saori Takamura, Yuichi Teraki, Eri Katayama, Takumi Kawaguchi, Machiko Kawaguchi, Dan Nakano, Tsubasa Tsutsumi, Sumiko Nagoshi, Takekuni Nakama, Takuji Torimura
- Clin Mol Hepatol. 2022;28(2):269-272. Published online February 15, 2022
-
View: 2233 Download: 225 Citations: 3
- Reply: Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis
- Jihyun An, Ju Hyun Shim
- Clin Mol Hepatol. 2022;28(2):267-268. Published online January 18, 2022
-
View: 1480 Download: 38
- Letter: cervicocerebral atherosclerosis and its hepatic and coronary risk factors in patients with liver cirrhosis
- Yi-Chun Huang, Chih-Wei Chen, James Chun-Chung Wei
- Clin Mol Hepatol. 2022;28(2):265-266. Published online January 4, 2022
-
View: 4967 Download: 34 Citation: 1
- Impact of branched-chain amino acids and frailty on the management of lenvatinib-related fatigue in patients with hepatocellular carcinoma
- Shigeo Shimose, Shunji Koya, Takumi Kawaguchi, Keisuke Hirota, Sachiyo Yoshio, Takashi Niizeki, Hiroo Matsuse, Takuji Torimura
- Clin Mol Hepatol. 2021;27(4):616-619. Published online September 13, 2021
-
View: 2631 Download: 176 Citation: 1
- The major diagnostic role of autoantibodies in the diagnosis of autoimmune hepatitis, a disease of all ages
- Linda Beenet
- Clin Mol Hepatol. 2021;27(3):510-511. Published online March 22, 2021
-
View: 2236 Download: 124 Citation: 1
- Clinical and serological prognostic markers in primary biliary cholangitis
- Markus Wilhelmi
- Clin Mol Hepatol. 2021;27(2):360-361. Published online March 23, 2021
-
View: 2164 Download: 94
- A dilemma that probably would never resolve
- Ravi Thanage, Shubham Jain, Sanjay Chandnani, Pravin Rathi
- Clin Mol Hepatol. 2021;27(1):219-220. Published online December 3, 2020
-
View: 2061 Download: 64
- Lean non-alcoholic fatty liver disease: Is there a place for novel antidiabetics in the therapeutic management of this underappreciated “enemy”?
- Dimitrios Patoulias, Michael Doumas
- Clin Mol Hepatol. 2020;26(4):582-583. Published online September 25, 2020
-
View: 2267 Download: 63
- Phosphoinositide 3-kinase inhibitors are effective therapeutic drugs for the treatment of hepatocellular carcinoma?
- Jeong Su Park, Soo Han Bae
- Clin Mol Hepatol. 2020;26(4):577-578. Published online September 17, 2020
-
View: 2348 Download: 57 Citation: 1
- Macro-aspartate aminotransferase in a healthy woman
- Maria Lorubbio, Agostino Ognibene, Benedetta Salvadori, Alessandra Fanelli, Giacomo Laffi
- Clin Mol Hepatol. 2020;26(3):378-381. Published online June 23, 2020
-
View: 3159 Download: 111 Citation: 1
- How does low-level viremia affect the prognosis of patients with chronic hepatitis B?
- Hye Won Lee, Beom Kyung Kim
- Clin Mol Hepatol. 2020;26(3):376-377. Published online June 11, 2020
-
View: 2993 Download: 104 Citation: 1
- Limited expression of toll-like receptor 9 on T cells and its functional consequences in patients with nonalcoholic fatty liver disease
- Jung Hwan Yu
- Clin Mol Hepatol. 2020;26(2):240-241. Published online March 23, 2020
-
View: 2785 Download: 40
- Intricate interpretation of etiology-specific outcome comparison in patients with hepatocellular carcinoma
- Hwi Young Kim, Jean-François Dufour
- Clin Mol Hepatol. 2020;26(2):238-239. Published online March 18, 2020
-
View: 2895 Download: 55 Citation: 1
- Does limited expression of toll-like receptor 9 actually contribute to T cell activation and liver damage in nonalcoholic steatohepatitis?
- Hyuk Soo Eun
- Clin Mol Hepatol. 2020;26(2):236-237. Published online April 7, 2020
-
View: 2419 Download: 44
- A challenge in distinguishing between acute hepatitis B and acute exacerbation of chronic hepatitis B
- Yang-Hyun Baek
- Clin Mol Hepatol. 2020;26(2):233-235. Published online April 7, 2020
-
View: 2896 Download: 94
- Fibrolamellar hepatocellular carcinoma-related hyperammonemic encephalopathy: Up to now and next steps
- Rodrigo Cañada Trofo Surjan, Elizabeth Santana dos Santos, Sergio do Prado Silveira, Fabio Ferrari Makdissi, Marcel Autran Cesar Machado
- Clin Mol Hepatol. 2020;26(2):231-232. Published online November 4, 2019
-
View: 3055 Download: 83 Citation: 1
- Multimodal sequential treatment for occluded TIPS: Case report and review of literature
- Nicoletta De Matthaeis, Carmine Di Stasi, Fabrizio Pizzolante, Riccardo Manfredi, Gian Ludovico Rapaccini, Luca Miele
- Clin Mol Hepatol. 2020;26(2):227-230. Published online November 18, 2019
-
View: 4174 Download: 143
-
Clinical and
Molecular
HepatologyPrint ISSN: 2287-2728
Online ISSN: 2287-285X
-
-
- Artificial intelligence in hepatology, Guest editor: Jeong Won Jang, M.D.
- Novel biomarkers for hepatocellular carcinoma, Guest editor: Bo Hyun Kim, M.D.
- Recent update on therapeutics for NAFLD, Guest editor: Won Kim, M.D.
- Interactions between metabolic phenotypes and chronic liver diseases, Guest editor: Dae Won Jun, M.D.
- All about risk models in hepatocellular carcinoma, Guest editor: Ji Hoon Kim, M.D.
- Epidemiology and updated management for autoimmune liver disease
- Microbiome and metabolomics in alcoholic liver disease
- Personalized medicine in nonalcoholic fatty liver disease
- Acute on chronic liver failure in cirrhosis
- Current status and outcome of liver transplantation in South Korea
- History and future of hepatitis B virus control in South Korea
- Hepatocellular carcinoma statistics in South Korea
First decision
09 Days
Publication after acceptance
06 Days
*Last 12 months
- MOST VIEWED (Last 6 months)
- MOST CITED (2021-2023)
|
|||||||
